Glucose, gallbladder, and pancreas considerations Tirzepatide can lower blood glucose, especially when used with insulin or insulin-releasing medicines such as sulfonylureas
But its GI side effect profile is also the most aggressive, with nausea rates reaching 40% to 50% and vomiting rates significantly higher than cagrilintide monotherapy
Both need to be kept at -20C 5C, but Cagrilintide is a little more sensitive to freeze-thaw cycles because of its molecular weight and disulfide bridges
How GHK-Cu Affects Skin and Collagen Production Most of the early excitement came from what GHK-Cu does to skin
Into, T., Inomata, M., Shibata, K., and Murakami, Y., Cell